| |NOVEMBER 20244India's drug discovery & development startup ecosystem is undergoing a boom, driven by technological advancements, the rise in talent pool and governmental initiatives. India is historically famous for its dominance in the generic drug manufacturing but is gradually shifting from the generic to innovative drug discovery, leveraging the new fields such as artificial intelligence (AI), and data science. These technologies are changing the landscape by speeding up and making the drug development more efficient, while reducing costs, and setting the stage for precision medicine. Research and development (R&D) is gaining prominence for the country's pharmaceutical industry. Indian startups' focus on biotechnology is now turning towards gene therapy, personalized medicine and novel drug delivery systems. Collaborations between the private sector, academia and government further support these advancements, and together, help to strengthen the robustness of the India innovation pipeline, and align with the needs of global healthcare.Concurrently, the Indian government has passed a number of policies to improve regulation and offer financial incentive for R&D work. It is essential because one of the biggest challenges in getting indigenous drug discovery companies off the ground has been limited infrastructure and funding. As India continues to grow rapidly, it is a promising drug discovery center for startups, which are leveraging top notch technologies to address both local and global healthcare issues. These continued developments position India well for it to emerge as a global leader not only in drug manufacturing, but also in discovery and development of next generation therapies. Keeping tabs on this market, India Pharma Outlook has shortlisted the select few startups that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghManaging Editoreditor@indiapharmaoutlook.comRedefining Drug Discovery Vol 2 · Issue 8 - 10 · November, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerV Hari PriyaSuanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >